Immunopathogenesis of Rheumatoid Arthritis

Immunity

Volumn 46, Issue 2, 2017, Pages 183-196

  Firestein, Gary S ^a   McInnes, Iain B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT;

CLINICAL TRIAL (TOPIC); COMORBIDITY; DRUG TARGETING; ENVIRONMENTAL STRESS; EPIGENETICS; EVOLUTION; GENETIC HETEROGENEITY; GENETICS; GENOME; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; META ANALYSIS (TOPIC); MOLECULAR PATHOLOGY; MUCOSAL DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STROMA CELL; SYNOVITIS; ANIMAL; IMMUNOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ARTHRITIS, RHEUMATOID; HUMANS;

EID: 85013957711     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2017.02.006     Document Type: Review

References (114)

1. Ahmed, A., Hollan, I., Curran, S.A., Kitson, S.M., Riggio, M.P., Mikkelsen, K., Almdahl, S.M., Aukrust, P., McInnes, I.B., Goodyear, C.S., Brief report: Proatherogenic cytokine microenvironment in the aortic adventitia of patients with rheumatoid arthritis. Arthritis Rheumatol. 68 (2016), 1361–1366.
2. Ai, R., Whitaker, J.W., Boyle, D.L., Tak, P.P., Gerlag, D.M., Wang, W., Firestein, G.S., DNA methylome signature in synoviocytes from patients with early rheumatoid arthritis compared to synoviocytes from patients with longstanding rheumatoid arthritis. Arthritis Rheumatol. 67 (2015), 1978–1980.
3. Ai, R., Hammaker, D., Boyle, D.L., Morgan, R., Walsh, A.M., Fan, S., Firestein, G.S., Wang, W., Joint-specific DNA methylation and transcriptome signatures in rheumatoid arthritis identify distinct pathogenic processes. Nat. Commun., 7, 2016, 11849.
4. Anzilotti, C., Merlini, G., Pratesi, F., Tommasi, C., Chimenti, D., Migliorini, P., Antibodies to viral citrullinated peptide in rheumatoid arthritis. J. Rheumatol. 33 (2006), 647–651.
5. Arend, W.P., Firestein, G.S., Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat. Rev. Rheumatol. 8 (2012), 573–586.
6. Astorri, E., Nerviani, A., Bombardieri, M., Pitzalis, C., Towards a stratified targeted approach with biologic treatments in rheumatoid arthritis: role of synovial pathobiology. Curr. Pharm. Des. 21 (2015), 2216–2224.
7. Benham, H., Nel, H.J., Law, S.C., Mehdi, A.M., Street, S., Ramnoruth, N., Pahau, H., Lee, B.T., Ng, J., Brunck, M.E., et al. Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients. Sci. Transl. Med., 7, 2015, 290ra87.
8. Bombardieri, M., Kam, N.W., Brentano, F., Choi, K., Filer, A., Kyburz, D., McInnes, I.B., Gay, S., Buckley, C., Pitzalis, C., A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Ann. Rheum. Dis. 70 (2011), 1857–1865.
9. Bottini, N., Firestein, G.S., Epigenetics in rheumatoid arthritis: a primer for rheumatologists. Curr. Rheumatol. Rep., 15, 2013, 372.
10. Bottini, N., Firestein, G.S., Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat. Rev. Rheumatol. 9 (2013), 24–33.
11. Byng-Maddick, R., Ehrenstein, M.R., The impact of biological therapy on regulatory T cells in rheumatoid arthritis. Rheumatology (Oxford) 54 (2015), 768–775.
12. Catrina, A.I., Ytterberg, A.J., Reynisdottir, G., Malmström, V., Klareskog, L., Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis. Nat. Rev. Rheumatol. 10 (2014), 645–653.
13. Catrina, A.I., Joshua, V., Klareskog, L., Malmström, V., Mechanisms involved in triggering rheumatoid arthritis. Immunol. Rev. 269 (2016), 162–174.
14. Charles-Schoeman, C., Fleischmann, R., Davignon, J., Schwartz, H., Turner, S.M., Beysen, C., Milad, M., Hellerstein, M.K., Luo, Z., Kaplan, I.V., et al. Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib. Arthritis Rheumatol. 67 (2015), 616–625.
15. Christophorou, M.A., Castelo-Branco, G., Halley-Stott, R.P., Oliveira, C.S., Loos, R., Radzisheuskaya, A., Mowen, K.A., Bertone, P., Silva, J.C., Zernicka-Goetz, M., et al. Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature 507 (2014), 104–108.
16. Corsiero, E., Bombardieri, M., Carlotti, E., Pratesi, F., Robinson, W., Migliorini, P., Pitzalis, C., Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs. Ann. Rheum. Dis. 75 (2016), 1866–1875.
17. Croft, A.P., Naylor, A.J., Marshall, J.L., Hardie, D.L., Zimmermann, B., Turner, J., Desanti, G., Adams, H., Yemm, A.I., Müller-Ladner, U., et al. Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage. Arthritis Res. Ther., 18, 2016, 270.
18. de Aquino, S.G., Abdollahi-Roodsaz, S., Koenders, M.I., van de Loo, F.A., Pruijn, G.J., Marijnissen, R.J., Walgreen, B., Helsen, M.M., van den Bersselaar, L.A., de Molon, R.S., et al. Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1-driven Th17 response. J. Immunol. 192 (2014), 4103–4111.
19. de Hair, M.J., van de Sande, M.G., Ramwadhdoebe, T.H., Hansson, M., Landewé, R., van der Leij, C., Maas, M., Serre, G., van Schaardenburg, D., Klareskog, L., et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 66 (2014), 513–522.
20. Deane, K.D., O'Donnell, C.I., Hueber, W., Majka, D.S., Lazar, A.A., Derber, L.A., Gilliland, W.R., Edison, J.D., Norris, J.M., Robinson, W.H., Holers, V.M., The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum. 62 (2010), 3161–3172.
21. Dennis, G. Jr., Holweg, C.T., Kummerfeld, S.K., Choy, D.F., Setiadi, A.F., Hackney, J.A., Haverty, P.M., Gilbert, H., Lin, W.Y., Diehl, L., et al. Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Res. Ther., 16, 2014, R90.
22. Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M.S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., et al. Dickkopf-1 is a master regulator of joint remodeling. Nat. Med. 13 (2007), 156–163.
23. Ekwall, A.K., Whitaker, J.W., Hammaker, D., Bugbee, W.D., Wang, W., Firestein, G.S., The rheumatoid arthritis risk gene LBH regulates growth in fibroblast-like synoviocytes. Arthritis Rheumatol. 67 (2015), 1193–1202.
24. El-Gabalawy, H.S., Robinson, D.B., Hart, D., Elias, B., Markland, J., Peschken, C.A., Smolik, I., Montes-Aldana, G., Schroeder, M., Fritzler, M.J., et al. Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives. J. Rheumatol. 36 (2009), 1130–1135.
25. Ferreira, R.C., Freitag, D.F., Cutler, A.J., Howson, J.M., Rainbow, D.B., Smyth, D.J., Kaptoge, S., Clarke, P., Boreham, C., Coulson, R.M., et al. Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases. PLoS Genet., 9, 2013, e1003444.
26. Filer, A., The fibroblast as a therapeutic target in rheumatoid arthritis. Curr. Opin. Pharmacol. 13 (2013), 413–419.
27. Firestein, G.S., Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum. 39 (1996), 1781–1790.
28. Firestein, G.S., Evolving concepts of rheumatoid arthritis. Nature 423 (2003), 356–361.
29. Firestein, G.S., The disease formerly known as rheumatoid arthritis. Arthritis Res. Ther., 16, 2014, 114.
30. Firestein, G.S., Zvaifler, N.J., How important are T cells in chronic rheumatoid synovitis?: II. T cell-independent mechanisms from beginning to end. Arthritis Rheum. 46 (2002), 298–308.
31. Firestein, G.S., Echeverri, F., Yeo, M., Zvaifler, N.J., Green, D.R., Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc. Natl. Acad. Sci. USA 94 (1997), 10895–10900.
32. Fonseca, J.E., Cavaleiro, J., Teles, J., Sousa, E., Andreozzi, V.L., Antunes, M., Amaral-Turkman, M.A., Canhão, H., Mourão, A.F., Lopes, J., et al. Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter. Arthritis Res. Ther., 9, 2007, R37.
33. Franz, J.K., Pap, T., Hummel, K.M., Nawrath, M., Aicher, W.K., Shigeyama, Y., Müller-Ladner, U., Gay, R.E., Gay, S., Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum. 43 (2000), 599–607.
34. Genovese, M.C., Kremer, J., Zamani, O., Ludivico, C., Krogulec, M., Xie, L., Beattie, S.D., Koch, A.E., Cardillo, T.E., Rooney, T.P., et al. Baricitinib in patients with refractory rheumatoid arthritis. N. Engl. J. Med. 374 (2016), 1243–1252.
35. Hammaker, D., Whitaker, J.W., Maeshima, K., Boyle, D.L., Ekwall, A.H., Wang, W., Firestein, G.S., Limb bud and heart development gene transcription is regulated by the interplay of an enhancer risk allele and DNA methylation in rheumatoid arthritis. Arthritis Rheumatol. 68 (2016), 2637–2645.
36. Harre, U., Georgess, D., Bang, H., Bozec, A., Axmann, R., Ossipova, E., Jakobsson, P.J., Baum, W., Nimmerjahn, F., Szarka, E., et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest. 122 (2012), 1791–1802.
37. ∗0401 MHC class II molecule. J. Immunol. 171 (2003), 538–541.
38. Horiuchi, M., Morinobu, A., Chin, T., Sakai, Y., Kurosaka, M., Kumagai, S., Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts. J. Rheumatol. 36 (2009), 1580–1589.
39. Huber, L.C., Brock, M., Hemmatazad, H., Giger, O.T., Moritz, F., Trenkmann, M., Distler, J.H., Gay, R.E., Kolling, C., Moch, H., et al. Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum. 56 (2007), 1087–1093.
40. Joosten, L.A., Leoni, F., Meghji, S., Mascagni, P., Inhibition of HDAC activity by ITF2357 ameliorates joint inflammation and prevents cartilage and bone destruction in experimental arthritis. Mol. Med. 17 (2011), 391–396.
41. Juarez, M., Bang, H., Hammar, F., Reimer, U., Dyke, B., Sahbudin, I., Buckley, C.D., Fisher, B., Filer, A., Raza, K., Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis. Ann. Rheum. Dis. 75 (2016), 1099–1107.
42. Källberg, H., Ding, B., Padyukov, L., Bengtsson, C., Rönnelid, J., Klareskog, L., Alfredsson, L., EIRA Study Group. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann. Rheum. Dis. 70 (2011), 508–511.
43. Kaminsky, Z.A., Tang, T., Wang, S.C., Ptak, C., Oh, G.H., Wong, A.H., Feldcamp, L.A., Virtanen, C., Halfvarson, J., Tysk, C., et al. DNA methylation profiles in monozygotic and dizygotic twins. Nat. Genet. 41 (2009), 240–245.
44. Karouzakis, E., Rengel, Y., Jüngel, A., Kolling, C., Gay, R.E., Michel, B.A., Tak, P.P., Gay, S., Neidhart, M., Ospelt, C., DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes Immun. 12 (2011), 643–652.
45. Kelly, S., Humby, F., Filer, A., Ng, N., Di Cicco, M., Hands, R.E., Rocher, V., Bombardieri, M., D'Agostino, M.A., McInnes, I.B., et al. Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients. Ann. Rheum. Dis. 74 (2015), 611–617.
46. Kiener, H.P., Niederreiter, B., Lee, D.M., Jimenez-Boj, E., Smolen, J.S., Brenner, M.B., Cadherin 11 promotes invasive behavior of fibroblast-like synoviocytes. Arthritis Rheum. 60 (2009), 1305–1310.
47. Kim, K., Bang, S.Y., Lee, H.S., Bae, S.C., Update on the genetic architecture of rheumatoid arthritis. Nat. Rev. Rheumatol. 13 (2017), 13–24.
48. Kinslow, J.D., Blum, L.K., Deane, K.D., Demoruelle, M.K., Okamoto, Y., Parish, M.C., Kongpachith, S., Lahey, L.J., Norris, J.M., Robinson, W.H., Holers, V.M., Elevated IgA plasmablast levels in subjects at risk of developing rheumatoid arthritis. Arthritis Rheumatol. 68 (2016), 2372–2383.
49. Kirschmann, D.A., Duffin, K.L., Smith, C.E., Welply, J.K., Howard, S.C., Schwartz, B.D., Woulfe, S.L., Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles. J. Immunol. 155 (1995), 5655–5662.
50. Klarenbeek, P.L., de Hair, M.J., Doorenspleet, M.E., van Schaik, B.D., Esveldt, R.E., van de Sande, M.G., Cantaert, T., Gerlag, D.M., Baeten, D., van Kampen, A.H., et al. Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease. Ann. Rheum. Dis. 71 (2012), 1088–1093.
51. Konig, M.F., Abusleme, L., Reinholdt, J., Palmer, R.J., Teles, R.P., Sampson, K., Rosen, A., Nigrovic, P.A., Sokolove, J., Giles, J.T., et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci. Transl. Med., 8, 2016, 369ra176.
52. Konig, M.F., Giles, J.T., Nigrovic, P.A., Andrade, F., Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis. Ann. Rheum. Dis. 75 (2016), 2022–2028.
53. Krishnadas, R., Nicol, A., Sassarini, J., Puri, N., Burden, A.D., Leman, J., Combet, E., Pimlott, S., Hadley, D., McInnes, I.B., Cavanagh, J., Circulating tumour necrosis factor is highly correlated with brainstem serotonin transporter availability in humans. Brain Behav. Immun. 51 (2016), 29–38.
54. Krishnamurthy, A., Joshua, V., Haj Hensvold, A., Jin, T., Sun, M., Vivar, N., Ytterberg, A.J., Engström, M., Fernandes-Cerqueira, C., Amara, K., et al. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann. Rheum. Dis. 75 (2016), 721–729.
55. Langley, R.G., Elewski, B.E., Lebwohl, M., Reich, K., Griffiths, C.E., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. ERASURE Study Group, FIXTURE Study Group. Secukinumab in plaque psoriasis–results of two phase 3 trials. N. Engl. J. Med. 371 (2014), 326–338.
56. Law, S.C., Street, S., Yu, C.H., Capini, C., Ramnoruth, S., Nel, H.J., van Gorp, E., Hyde, C., Lau, K., Pahau, H., et al. T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles. Arthritis Res. Ther., 14, 2012, R118.
57. Lee, E.B., Fleischmann, R., Hall, S., Wilkinson, B., Bradley, J.D., Gruben, D., Koncz, T., Krishnaswami, S., Wallenstein, G.V., Zang, C., et al., ORAL Start Investigators. Tofacitinib versus methotrexate in rheumatoid arthritis. N. Engl. J. Med. 370 (2014), 2377–2386.
58. Lefèvre, S., Knedla, A., Tennie, C., Kampmann, A., Wunrau, C., Dinser, R., Korb, A., Schnäker, E.M., Tarner, I.H., Robbins, P.D., et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat. Med. 15 (2009), 1414–1420.
59. Linn-Rasker, S.P., van der Helm-van Mil, A.H., van Gaalen, F.A., Kloppenburg, M., de Vries, R.R., le Cessie, S., Breedveld, F.C., Toes, R.E., Huizinga, T.W., Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann. Rheum. Dis. 65 (2006), 366–371.
60. Liu, X., Zeng, B., Zhang, J., Li, W., Mou, F., Wang, H., Zou, Q., Zhong, B., Wu, L., Wei, H., Fang, Y., Role of the gut microbiome in modulating arthritis progression in mice. Sci. Rep., 6, 2016, 30594.
61. Lubberts, E., The IL-23-IL-17 axis in inflammatory arthritis. Nat. Rev. Rheumatol. 11 (2015), 415–429.
62. Lundström, E., Källberg, H., Alfredsson, L., Klareskog, L., Padyukov, L., Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. Arthritis Rheum. 60 (2009), 1597–1603.
63. Makrygiannakis, D., Hermansson, M., Ulfgren, A.K., Nicholas, A.P., Zendman, A.J., Eklund, A., Grunewald, J., Skold, C.M., Klareskog, L., Catrina, A.I., Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann. Rheum. Dis. 67 (2008), 1488–1492.
64. Matsumoto, I., Maccioni, M., Lee, D.M., Maurice, M., Simmons, B., Brenner, M., Mathis, D., Benoist, C., How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat. Immunol. 3 (2002), 360–365.
65. McInnes, I.B., Schett, G., Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7 (2007), 429–442.
66. McInnes, I.B., Schett, G., The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365 (2011), 2205–2219.
67. McInnes, I.B., Mease, P.J., Kirkham, B., Kavanaugh, A., Ritchlin, C.T., Rahman, P., van der Heijde, D., Landewé, R., Conaghan, P.G., Gottlieb, A.B., et al., FUTURE 2 Study Group. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomized, double-blind, placebo-controlled, phase 3 trial. Lancet 386 (2015), 1137–1146.
68. McInnes, I.B., Buckley, C.D., Isaacs, J.D., Cytokines in rheumatoid arthritis - shaping the immunological landscape. Nat. Rev. Rheumatol. 12 (2016), 63–68.
69. McKellar, G.E., McCarey, D.W., Sattar, N., McInnes, I.B., Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat. Rev. Cardiol. 6 (2009), 410–417.
70. Miossec, P., Kolls, J.K., Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11 (2012), 763–776.
71. Müller-Ladner, U., Kriegsmann, J., Franklin, B.N., Matsumoto, S., Geiler, T., Gay, R.E., Gay, S., Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol. 149 (1996), 1607–1615.
72. Mydel, P., Wang, Z., Brisslert, M., Hellvard, A., Dahlberg, L.E., Hazen, S.L., Bokarewa, M., Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis. J. Immunol. 184 (2010), 6882–6890.
73. Nakamachi, Y., Kawano, S., Takenokuchi, M., Nishimura, K., Sakai, Y., Chin, T., Saura, R., Kurosaka, M., Kumagai, S., MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 60 (2009), 1294–1304.
74. Nakano, K., Whitaker, J.W., Boyle, D.L., Wang, W., Firestein, G.S., DNA methylome signature in rheumatoid arthritis. Ann. Rheum. Dis. 72 (2013), 110–117.
75. Nakano, K., Boyle, D.L., Firestein, G.S., Regulation of DNA methylation in rheumatoid arthritis synoviocytes. J. Immunol. 190 (2013), 1297–1303.
76. Nam, J.L., Ramiro, S., Gaujoux-Viala, C., Takase, K., Leon-Garcia, M., Emery, P., Gossec, L., Landewe, R., Smolen, J.S., Buch, M.H., Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann. Rheum. Dis. 73 (2014), 516–528.
77. Okada, Y., Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Kochi, Y., Ohmura, K., Suzuki, A., Yoshida, S., et al. RACI consortium, GARNET consortium. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506 (2014), 376–381.
78. Pap, T., Franz, J.K., Hummel, K.M., Jeisy, E., Gay, R., Gay, S., Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res. 2 (2000), 59–64.
79. Perlman, H., Bradley, K., Liu, H., Cole, S., Shamiyeh, E., Smith, R.C., Walsh, K., Fiore, S., Koch, A.E., Firestein, G.S., et al. IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts. J. Immunol. 170 (2003), 838–845.
80. Pitzalis, C., Jones, G.W., Bombardieri, M., Jones, S.A., Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat. Rev. Immunol. 14 (2014), 447–462.
81. Randen, I., Brown, D., Thompson, K.M., Hughes-Jones, N., Pascual, V., Victor, K., Capra, J.D., Førre, O., Natvig, J.B., Clonally related IgM rheumatoid factors undergo affinity maturation in the rheumatoid synovial tissue. J. Immunol. 148 (1992), 3296–3301.
82. Rawlings, D.J., Dai, X., Buckner, J.H., The role of PTPN22 risk variant in the development of autoimmunity: finding common ground between mouse and human. J. Immunol. 194 (2015), 2977–2984.
83. Raychaudhuri, S., Sandor, C., Stahl, E.A., Freudenberg, J., Lee, H.S., Jia, X., Alfredsson, L., Padyukov, L., Klareskog, L., Worthington, J., et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44 (2012), 291–296.
84. Raza, K., Falciani, F., Curnow, S.J., Ross, E.J., Lee, C.Y., Akbar, A.N., Lord, J.M., Gordon, C., Buckley, C.D., Salmon, M., Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res. Ther. 7 (2005), R784–R795.
85. Reynisdottir, G., Karimi, R., Joshua, V., Olsen, H., Hensvold, A.H., Harju, A., Engström, M., Grunewald, J., Nyren, S., Eklund, A., et al. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol. 66 (2014), 31–39.
86. Reynisdottir, G., Olsen, H., Joshua, V., Engström, M., Forsslund, H., Karimi, R., Sköld, C.M., Nyren, S., Eklund, A., Grunewald, J., Catrina, A.I., Signs of immune activation and local inflammation are present in the bronchial tissue of patients with untreated early rheumatoid arthritis. Ann. Rheum. Dis. 75 (2016), 1722–1727.
87. Robertson, J., Peters, M.J., McInnes, I.B., Sattar, N., Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nat. Rev. Rheumatol. 9 (2013), 513–523.
88. Rodríguez-Carrio, J., Hähnlein, J.S., Ramwadhdoebe, T.H., Semmelink, J.F., Choi, I.Y., van Lienden, K.P., Maas, M., Gerlag, D.M., Tak, P.P., Geijtenbeek, T.B., van Baarsen, L.G., Altered innate lymphoid cells subsets in human lymph node biopsies during the at risk and earliest phase of rheumatoid arthritis. Arthritis Rheumatol. 69 (2016), 70–76.
89. Rombouts, Y., Ewing, E., van de Stadt, L.A., Selman, M.H., Trouw, L.A., Deelder, A.M., Huizinga, T.W., Wuhrer, M., van Schaardenburg, D., Toes, R.E., Scherer, H.U., Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann. Rheum. Dis. 74 (2015), 234–241.
90. Rossetti, M., Spreafico, R., Consolaro, A., Leong, J.Y., Chua, C., Massa, M., Saidin, S., Magni-Manzoni, S., Arkachaisri, T., Wallace, C.A., et al. TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis. Ann. Rheum. Dis. 76 (2017), 435–441.
91. Scally, S.W., Petersen, J., Law, S.C., Dudek, N.L., Nel, H.J., Loh, K.L., Wijeyewickrema, L.C., Eckle, S.B., van Heemst, J., Pike, R.N., et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J. Exp. Med. 210 (2013), 2569–2582.
92. Scher, J.U., Sczesnak, A., Longman, R.S., Segata, N., Ubeda, C., Bielski, C., Rostron, T., Cerundolo, V., Pamer, E.G., Abramson, S.B., et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife, 2, 2013, e01202.
93. Schiff, M., Weinblatt, M.E., Valente, R., van der Heijde, D., Citera, G., Elegbe, A., Maldonado, M., Fleischmann, R., Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial. Ann. Rheum. Dis. 73 (2014), 86–94.
94. Shi, J., Knevel, R., Suwannalai, P., van der Linden, M.P., Janssen, G.M., van Veelen, P.A., Levarht, N.E., van der Helm-van Mil, A.H., Cerami, A., Huizinga, T.W., et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc. Natl. Acad. Sci. USA 108 (2011), 17372–17377.
95. Shi, J., van de Stadt, L.A., Levarht, E.W., Huizinga, T.W., Hamann, D., van Schaardenburg, D., Toes, R.E., Trouw, L.A., Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann. Rheum. Dis. 73 (2014), 780–783.
96. Smolen, J.S., Aletaha, D., Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges. Nat. Rev. Rheumatol. 11 (2015), 276–289.
97. Smolen, J.S., Aletaha, D., McInnes, I.B., Rheumatoid arthritis. Lancet 388 (2016), 2023–2038.
98. ∗0401-positive humanized mice and rheumatoid arthritis patients. Arthritis Rheum. 63 (2011), 2873–2883.
99. Sokolove, J., Zhao, X., Chandra, P.E., Robinson, W.H., Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor. Arthritis Rheum. 63 (2011), 53–62.
100. Stanczyk, J., Ospelt, C., Karouzakis, E., Filer, A., Raza, K., Kolling, C., Gay, R., Buckley, C.D., Tak, P.P., Gay, S., Kyburz, D., Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum. 63 (2011), 373–381.
101. Suzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., Suzuki, M., Nagasaki, M., Nakayama-Hamada, M., Kawaida, R., Ono, M., et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34 (2003), 395–402.
102. Tan, E.M., Smolen, J.S., Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor. J. Exp. Med. 213 (2016), 1937–1950.
103. Tran, C.N., Davis, M.J., Tesmer, L.A., Endres, J.L., Motyl, C.D., Smuda, C., Somers, E.C., Chung, K.C., Urquhart, A.G., Lundy, S.K., et al. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes. Arthritis Rheum. 56 (2007), 1497–1506.
104. Tsaprouni, L.G., Yang, T.P., Bell, J., Dick, K.J., Kanoni, S., Nisbet, J., Viñuela, A., Grundberg, E., Nelson, C.P., Meduri, E., et al. Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation. Epigenetics 9 (2014), 1382–1396.
105. van Beers, J.J., Willemze, A., Jansen, J.J., Engbers, G.H., Salden, M., Raats, J., Drijfhout, J.W., van der Helm-van Mil, A.H., Toes, R.E., Pruijn, G.J., ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression. Arthritis Res. Ther., 15, 2013, R140.
106. van der Helm-van Mil, A.H., Verpoort, K.N., Breedveld, F.C., Huizinga, T.W., Toes, R.E., de Vries, R.R., The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum. 54 (2006), 1117–1121.
107. Vassallo, R., Luckey, D., Behrens, M., Madden, B., Luthra, H., David, C., Taneja, V., Cellular and humoral immunity in arthritis are profoundly influenced by the interaction between cigarette smoke effects and host HLA-DR and DQ genes. Clin. Immunol. 152 (2014), 25–35.
108. Wang, Y., Shaked, I., Stanford, S.M., Zhou, W., Curtsinger, J.M., Mikulski, Z., Shaheen, Z.R., Cheng, G., Sawatzke, K., Campbell, A.M., et al. The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity 39 (2013), 111–122.
109. Wegner, N., Wait, R., Sroka, A., Eick, S., Nguyen, K.A., Lundberg, K., Kinloch, A., Culshaw, S., Potempa, J., Venables, P.J., Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 62 (2010), 2662–2672.
110. Weyand, C.M., Hicok, K.C., Conn, D.L., Goronzy, J.J., The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann. Intern. Med. 117 (1992), 801–806.
111. Yamamoto, K., Okada, Y., Suzuki, A., Kochi, Y., Genetics of rheumatoid arthritis in Asia–present and future. Nat. Rev. Rheumatol. 11 (2015), 375–379.
112. Yang, Z., Shen, Y., Oishi, H., Matteson, E.L., Tian, L., Goronzy, J.J., Weyand, C.M., Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis. Sci. Transl. Med., 8, 2016, 331ra38.
113. Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., Wu, X., Li, J., Tang, L., Li, Y., et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 21 (2015), 895–905.
114. Zvaifler, N.J., Boyle, D., Firestein, G.S., Early synovitis–synoviocytes and mononuclear cells. Semin. Arthritis Rheum. 23:6, Suppl 2 (1994), 11–16.